Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00784030 · ClinicalTrials.gov registry record · NA
High Water Intake to Slow Progression of Polycystic Kidney Disease
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT00784030 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 23 participants.
The verdict
NCT00784030, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
Polycystic kidney disease (PKD) is a genetic disease that occurs in 1 in 500 individuals and leads to kidney failure in half of all affected. Currently, no treatments exist for PKD. PKD-affected kidney cells divide and multiply inappropriately, and form fluid-filled sacs called cysts. Kidney cysts continue to grow throughout life, destroying normal kidney tissue, leading to kidney failure. Based on evidence from basic science research it is believed that drinking high amounts of water can slow the abnormal cysts growth. This study aims to look at changes in urine composition with high water intake in PKD-affected persons compared to healthy individuals.
Interventions
- OTHER Water
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2008-11 |
| Est. Completion | 2009-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00784030
The ClinicalTrials.gov registry entry for NCT00784030 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Water is the first listed.
NCT00784030 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00784030 about?
NCT00784030 is a clinical study titled "High Water Intake to Slow Progression of Polycystic Kidney Disease". Polycystic kidney disease (PKD) is a genetic disease that occurs in 1 in 500 individuals and leads to kidney failure in half of all affected. Currently, no treatments exist for PKD. PKD-affected kidney cells divide and multiply inappropriately, and form fluid-filled sacs called cysts. Kidney cysts c...
What is the current status of trial NCT00784030?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2008-11. Estimated completion is 2009-05.
What interventions are being tested in trial NCT00784030?
The interventions under investigation include: Water (OTHER).
Who is sponsoring clinical trial NCT00784030?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.